Lobbying Spend
—
Filings
68
Firms Hired
1
Active Period
2010–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · second_quarter · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · first_quarter · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.5343
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · fourth_quarter · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.5343
Issues related to FDA approval of medical devices. Barriers to market access for medical device companies. Supply chain issues related to semiconductors. H.R. 5389/S. 2654, The REDUCE Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5389
September 11 Transparency Act of 2021
2021 · fourth_quarter · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Barriers to market access for medical device companies. Supply chain issues related to semiconductors. H.R. 5389/S. 2654, The REDUCE Act.
Client expense: — · Firm income: $20,000
Matched citations: S. 2654
Issues related to FDA approval of medical devices. Barriers to market access for medical device companies. Supply chain issues related to semiconductors. H.R. 5389/S. 2654, The REDUCE Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5389
September 11 Transparency Act of 2021
2021 · third_quarter · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Barriers to market access for medical device companies. Supply chain issues related to semiconductors. H.R. 5389/S. 2654, The REDUCE Act.
Client expense: — · Firm income: $20,000
Matched citations: S. 2654
American Rescue Plan Act of 2021
2021 · first_quarter · Firm: THORN RUN PARTNERS
Issues related to pandemic related relief for small medical device manufacturing. H.R. 1319, American Rescue Plan of 2021.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1319
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: THORN RUN PARTNERS
Issues related to pandemic related relief for small medical device manufacturing businesses. Issues related to FDA approval of medical devices. Barriers to market access for medical device companies. H.R. 133, Consolidating Appropriations Act, 2021.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 133
Issues related to pandemic related relief for small medical device manufacturing businesses. Issues related to FDA approval of medical devices. Barriers to market access for medical device companies. The Cares Act, Public Law 116-136. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act. Senate COVID-19 response legislation.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6800
Issues related to pandemic related relief for small medical device manufacturing businesses. Issues related to FDA approval of medical devices. Barriers to market access for medical device companies. The Cares Act, Public Law 116-136. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act. Senate COVID-19 response legislation.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6800
Protect Medical Innovation Act of 2015
2015 · fourth_quarter · Firm: THORN RUN PARTNERS
H.R.160, Protect Medical Innovation Act of 2015. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L.111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R.160
Protect Medical Innovation Act of 2015
2015 · third_quarter · Firm: THORN RUN PARTNERS
H.R.160, Protect Medical Innovation Act of 2015. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L.111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R.160
Protect Medical Innovation Act of 2015
2015 · second_quarter · Firm: THORN RUN PARTNERS
H.R.160, Protect Medical Innovation Act of 2015. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L.111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R.160
Protect Medical Innovation Act of 2015
2015 · first_quarter · Firm: THORN RUN PARTNERS
H.R.160, Protect Medical Innovation Act of 2015. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L.111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R.160
Protect Medical Innovation Act of 2013
2014 · fourth_quarter · Firm: THORN RUN PARTNERS
H.R.523, Protect Medical Innovation Act of 2013; S.232, Medical Device Access and Innovation Protection Act. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L. 111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R.523
Medical Device Access and Innovation Protection Act
2014 · fourth_quarter · Firm: THORN RUN PARTNERS
H.R.523, Protect Medical Innovation Act of 2013; S.232, Medical Device Access and Innovation Protection Act. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L. 111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: S.232
Protect Medical Innovation Act of 2013
2014 · third_quarter · Firm: THORN RUN PARTNERS
H.R.523, Protect Medical Innovation Act of 2013; S.232, Medical Device Access and Innovation Protection Act. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L. 111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R.523
Medical Device Access and Innovation Protection Act
2014 · third_quarter · Firm: THORN RUN PARTNERS
H.R.523, Protect Medical Innovation Act of 2013; S.232, Medical Device Access and Innovation Protection Act. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L. 111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: S.232
Protect Medical Innovation Act of 2013
2014 · second_quarter · Firm: THORN RUN PARTNERS
H.R.523, Protect Medical Innovation Act of 2013; S.232, Medical Device Access and Innovation Protection Act. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L. 111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R.523
Medical Device Access and Innovation Protection Act
2014 · second_quarter · Firm: THORN RUN PARTNERS
H.R.523, Protect Medical Innovation Act of 2013; S.232, Medical Device Access and Innovation Protection Act. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L. 111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: S.232
Protect Medical Innovation Act of 2013
2014 · first_quarter · Firm: THORN RUN PARTNERS
H.R.523, Protect Medical Innovation Act of 2013; S.232, Medical Device Access and Innovation Protection Act. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L. 111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R.523
Medical Device Access and Innovation Protection Act
2014 · first_quarter · Firm: THORN RUN PARTNERS
H.R.523, Protect Medical Innovation Act of 2013; S.232, Medical Device Access and Innovation Protection Act. Issues related to legislation to repeal the medical device tax provision of the Patient Protection and Affordable Care Act (P.L. 111-148) and health care reform.
Client expense: — · Firm income: $20,000
Matched citations: S.232
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: THORN RUN PARTNERS
H.R.3590, Patient Protection and Affordable Care Act; H.R.4872, Health Care and Education Reconciliation Act of 2010. Issues related to health care reform legislation. Issues related to group purchasing organizations' Medicare Safe Harbor.
Client expense: — · Firm income: $20,000
Matched citations: H.R.3590
Source: Senate LDA